| BNIP3 |
Q12983
|
BCL2 interacting protein 3
|
|
2.0E-05 |
0.520 |
0.731 |
| PLAUR |
Q03405
|
plasminogen activator, urokinase receptor
|
|
5.3E-03 |
0.536 |
0.731 |
| NOX1 |
Q9Y5S8
|
NADPH oxidase 1
|
|
8.7E-08 |
0.536 |
0.808 |
| SUMO1 |
P63165
|
small ubiquitin like modifier 1
|
|
0.86 |
0.533 |
0.731 |
| EGLN1 |
Q9GZT9
|
egl-9 family hypoxia inducible factor 1
|
|
0.97 |
0.540 |
0.731 |
| MT2A |
P02795
|
metallothionein 2A
|
|
1.2E-05 |
0.553 |
0.808 |
| KAT2B |
Q92831
|
lysine acetyltransferase 2B
|
|
0.99 |
0.563 |
0.692 |
| SPINT2 |
O43291
|
serine peptidase inhibitor, Kunitz type 2
|
|
7.5E-04 |
0.556 |
0.808 |
| PMAIP1 |
Q13794
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
0.11 |
0.559 |
0.808 |
| TLR6 |
Q9Y2C9
|
toll like receptor 6
|
|
2.3E-05 |
0.556 |
0.769 |
| EGLN3 |
Q9H6Z9
|
egl-9 family hypoxia inducible factor 3
|
|
9.5E-03 |
0.575 |
0.654 |
| DDIT4 |
Q9NX09
|
DNA damage inducible transcript 4
|
|
6.8E-04 |
0.576 |
0.769 |
| CYGB |
Q8WWM9
|
cytoglobin
|
|
0.10 |
0.579 |
0.577 |
| USF1 |
P22415
|
upstream transcription factor 1
|
|
2.4E-02 |
0.592 |
0.692 |
| ALDOB |
P05062
|
aldolase, fructose-bisphosphate B
|
|
7.9E-07 |
0.623 |
0.538 |
| BARD1 |
Q99728
|
BRCA1 associated RING domain 1
|
|
1.4E-24 |
0.597 |
0.538 |
| KDM4C |
Q9H3R0
|
lysine demethylase 4C
|
|
6.5E-07 |
0.601 |
0.615 |
| ERRFI1 |
Q9UJM3
|
ERBB receptor feedback inhibitor 1
|
|
1.2E-02 |
0.612 |
0.538 |
| ASPH |
Q12797
|
aspartate beta-hydroxylase
|
|
6.6E-15 |
0.610 |
0.615 |
| CYP2J2 |
P51589
|
cytochrome P450 family 2 subfamily J member 2
|
|
1.6E-15 |
0.628 |
0.615 |
| TXNDC5 |
Q8NBS9
|
thioredoxin domain containing 5
|
|
4.9E-13 |
0.615 |
0.577 |
| DCD |
P81605
|
dermcidin
|
|
1.6E-04 |
0.619 |
0.654 |
| BNIP3L |
O60238
|
BCL2 interacting protein 3 like
|
|
0.15 |
0.636 |
0.654 |
| P4HTM |
Q9NXG6
|
prolyl 4-hydroxylase, transmembrane
|
|
3.9E-09 |
0.666 |
0.500 |
| USF2 |
Q15853
|
upstream transcription factor 2, c-fos interacting
|
|
0.99 |
0.626 |
0.654 |